Tax reform is positive, KPMA says

"We are positive about the recent tax revision of the Finance Ministry because it partly accepts our demand for tax cuts to ease the tax burden on the local pharmaceutical companies and upgrade the existing GMP facilities," said an official from the Korea Pharmaceutical Manufacturers Association. "But it is still unsatisfactory."

But more R&D reform-minded drug makers argued that, while the ...